1. Repository of OAI
Ελληνικά   English  

Browsing by Author Tselepis, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 62 to 78 of 78 < previous 
TitleAuthor(s)Issue date???itemlist.???
Mapping the Fibrinogen Binding Sites of the Platelet Receptor Using Synthetic Peptides Derived from the Beta 3 SubunitStathopoulos, P.; Rodis, F.; Naydenova, E.; Tsoukatos, D.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
Oxidative stress is progressively enhanced with advancing stages of chronic kidney diseaseDounousi, E.; Papavasiliou, E.; Makedou, A.; Ioannou, K.; Katododis, K.; Tselepis, A.; Siamopoulos, K.; Tsakiris, D.24-Nov-2015-
Oxidative stress is progressively enhanced with advancing stages of CKDDounousi, E.; Papavasiliou, E.; Makedou, A.; Ioannou, K.; Katopodis, K. P.; Tselepis, A.; Siamopoulos, K. C.; Tsakiris, D.24-Nov-2015-
Oxidative stress is progressively enhanced with advancing stages of CKDDounousi, E.; Papavasiliou, E.; Makedou, A.; Loannou, K.; Katopodis, K. P.; Tselepis, A.; Siamopoulos, K. C.; Tsakiris, D.24-Nov-2015-
Peptide analogues derived from the cytoplasmic domain of alpha IIB beta 3 integrin receptor inhibit platelet aggregationKoloka, V.; Stathopoulos, P.; Panou-Pomonis, E.; Vaxevanellis, S.; Dimitriou, A.; Tsironis, L.; Tsoukatos, D.; Tselepis, A.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tsikaris, V.24-Nov-2015-
Peptides Derived from Cytoplasmic Region of the Integrin Platelet Receptor as Anti-Aggregatory AgientsStathopoulos, P.; Koloka, V.; Rodis, F.; Mitsios, J.; Vaxevanellis, S.; Panou-Pomonis, E.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tsoukatos, D.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
Quantitative and qualitative changes of serum lipoproteins in patients with acute brucellosisApostolou, F.; Liberoloulos, E.; Gazi, I.; Tsouli, S.; Tsianos, E.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Reduced levels of HDL-associated PAF-acetylhydrolase activity in normolipidemic and dyslipidemic PON1 55LL carriersKakafika, A.; Tambaki, A.; Lourida, E.; Xenofontos, S.; Tsimihodimos, V.; Kalaitzidis, R.; Cariolou, M.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Selective imidazoline receptor agonists and lipid metabolismElisaf, M.; Tselepis, A.; Siamopoulos, K.24-Nov-2015-
Serum apolipoproteins as acute phase reactants in patients with infectionLiberopoulos, E.; Apostolou, F.; Seferiadis, K.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Structure activity relationship of peptide analogues derived from integrin subunit GPIIbStanica, R. M.; Benaki, D.; Tsoukatos, D.; Tselepis, A.; Mikros, E.; Tsikaris, V.24-Nov-2015-
Structure-activity relationships of alpha(IIb) 313-320 derived peptide inhibitors of human platelet aggregationStanica, R. M.; Benaki, D.; Rodis, F. I.; Mikros, E.; Tsoukatos, D.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
Studies on the apolipoprotein A-I region 104-117 and its lipopeptide analogue (substitution of Met112 by aminotetradecanoic acid) as potential antiatherogenicHarilogis, K.; Petraki, M.; Tselepis, A.; Sakarellos-Daitsiotis, M.; Sakarellos, C.24-Nov-2015-
Synthesis and anti-aggregatory activity of (S,S) -CDC- and GPIIB 313-320 derived hybrid analoguesVitouladiti, K.; Roufou, K.; Moussis, V.; Tsoukatos, D.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
Synthesis and anti-aggregatory activity of beta(EEb) 313-320 hybrid analogues incorporating the (S,S)-CDC-motifRoufou, K.; Vitouladiti, A.; Stathopoulou, E.; Moussis, V.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H(2)O(2) from DNA damageTselepis, A.; Doulias, P.; Lourida, E.; Glantzounis, G.; Tsimoyiannis, E.; Galaris, D.24-Nov-2015-
Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H2O2 from DNA damageTselepis, A.; Doulias, P. T.; Lourida, E.; Glantzounis, G.; Tsimoyiannis, E.; Galaris, D.24-Nov-2015-
Showing results 62 to 78 of 78 < previous